This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The search was restricted to articles published in English and Chinese languages. ConclusionsMotivational interviewing has been shown to effectively reduce blood pressure in the short term among individuals with hypertension, while simultaneously enhancing their self-efficacy, quality of life, and adherence to medication regimens.
It can be associated with reduced quality of life and complications such as heart failure and stroke. In this article, we present our approach to fluoroless radiofrequency PVI using ICE and 3D electro-anatomical mapping. Atrial fibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%.
Food and Drug Administration (FDA) this year for tricuspid regurgitation (TR) are safe, effective and improve quality of life (QOL) at one year, according to studies published in JACC and simultaneously being presented at TCT 2024. Two devices approved by the U.S.
In patients with obesity and heart failure with preserved ejection fraction (HFpEF), weekly treatment with tirzepatide over approximately two years reduced the risk of worsening heart failure events, based on findings from the SUMMIT trial.
Peripheral artery disease (PAD) represents a significant global health burden, affecting >200 million people and accounting for approximately 10-15% of the population >50 years of age.
Objective To investigate the association between health-related quality of life (HRQoL) and major adverse cardiovascular and cerebrovascular events (MACCE) in individuals with ischaemic heart disease (IHD). Results Fifty-one articles were included with a total of 134 740 participants from 53 countries. to 1.51).
The ADMINISTER trial aims to provide the first randomized controlled data on the impact of DCs on GDMT prescription rates, optimization time, healthcare efficiency, quality of life, and satisfaction for both patients and clinicians. Original article: Man JP et al. The results of this trial are eagerly anticipated.
The International Journal of Cardiovascular Sciences is pleased to invite Brazilian and international researchers to submit articles for the thematic collection on Artificial Intelligence in Cardiovascular Health , which will be edited by Dr. Erito Marques de Souza Filho and Dr. Roberto Botelho and published in 2025.
However, there is a paucity of information regarding the impact of AF on HCM employing validated quality of life (QoL) surveys. Therefore, we evaluated the impact of AF on QoL utilizing patient reported outcome measures (PROMs).
The goal of the phase 3b STRIDE trial was to evaluate the safety of once-weekly injections of the GLP-1 receptor agonist semaglutide and to determine whether it improves function (symptoms and quality of life [QoL]) in patients with symptomatic peripheral artery disease (PAD) and type 2 diabetes (T2D) with functional limitations.
While invasive interventions can restore selected patients’ quality of life, pharmacologic therapies that are safe, well-tolerated and that reliably improve how patients feel and function remain an unmet need for patients with obstructive HCM.
Semaglutide, compared to placebo, significantly improved walking distance, symptoms and quality of life in participants with symptomatic peripheral artery disease (PAD) and type 2 diabetes (T2D), according to results of the STRIDE study presented at ACC.25 25 in Chicago and simultaneously published in The Lancet.
The aim of this thematic collection is to gather high-qualityarticles that contribute to the advancement of knowledge about cardiac amyloidosis. Studies on quality of life. Original articles, review articles and case reports will be accepted. Pathophysiology of cardiac amyloidosis.
TAVR outcomes, with respect to post-surgical functional capacity and quality of life, have also been found to be improved, especially when combined with cardiac rehabilitation (CR).
The International Journal of Cardiovascular Sciences is pleased to invite Brazilian and international researchers to submit articles for the thematic collection on Artificial Intelligence in Cardiovascular Health , which will be edited by Dr. Erito Marques de Souza Filho and Dr. Roberto Botelho and published in 2025.
In this article, we’ll explore some of the leading fellowship specialties, what they entail, and the career paths they open for doctors committed to continuous learning and professional growth. Strong analytical skills, precision, and a desire to help patients recover mobility and quality of life are key traits.
This article is protected by copyright. Conclusions In the post hoc analysis of the myPACE trial, we observed that the benefits of a personalized accelerated backup pacing on MLHFQ score, NTproBNP, and pacemaker-detected activity levels appear to be more pronounced in patients with smaller iLVEDV and higher LVEF. All rights reserved.
In this study, we evaluated the change in left ventricular end-diastolic pressure (LVEDP) after primary percutaneous coronary intervention (PCI) and its impact on in-hospital outcomes and 30-day and three-month quality of life (SAQ-7), ejection fraction (EF), and major adverse cardiovascular events (MACE).
The 2022 ACC/ AHA/HFSA guideline on the management of HF recommends using renin-angiotensin-aldosterone system inhibitors with a preference for angiotensin receptor-neprilysin inhibitors (ARNIs), beta-blockers, mineralocorticoid receptor antagonists, and sodium glucose cotransporter 2 (SGLT2) inhibitors to improve survival, symptoms, ventricular function (..)
This article discusses their shared pathophysiology, focusing on the triad of hypertension, obesity, and aging.We This article discusses their shared pathophysiology, focusing on the triad of hypertension, obesity, and aging.We
Identifying new targeted therapeutic approaches has become a priority of biomedical research to improve patient outcomes and quality of life. In this article, we first describe how ERK signaling contributes to preserving cardiovascular health.
In this episode, Andrea Price, MS, AACC hosts Jae Patton, MSN, CRNP, AACC and Sarah Godfrey, MD, MPH to share insights for ensuring quality of life when time is short: tools for the end-stage heart failure care.
What is the impact of caval implantation of the TricValve system on quality of life (QOL) outcomes at 1 year among patients with severe symptomatic tricuspid regurgitation (TR)?
Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation (TR) and improved quality of life after one year, based on findings from the Tri.fr trial presented at ESC Congress 2024 in London.
Clinicians working with older patients have witnessed firsthand how polypharmacy can complicate both their care and diminish quality of life. had one or more severe potential drug-drug interaction.1 1 There has been a dramatic increase in the risk of drug-drug interactions and ADRs.
Results The search found 1378 articles. Diltiazem was found to decrease angina and increase quality of life until 12th week of treatment; however, some adverse effects include atrioventricular block and recurrent angina up till 4th week were found. However, six studies were selected after implementing the study criteria.
Iron deficiency (ID) is a common comorbidity among patients with heart failure (HF), and it is associated with reduced exercise tolerance and quality of life and serves as a marker of increased risk of hospitalizations and mortality.
Cardiovascular diseases pose a major threat to human life, functional activity, and quality of life. There is a consensus on the benefits of cardiac rehabilitation in improving patients’ quality of life, enhancing functional activity, and reducing mortality.
Only 25% of stroke survivors fully recover their prior level of functioning; 75% survive with some form of impairment, and half of them lose their capacity for self-sufficiency, which has a significantly negative impact on their quality of life.
Pulmonary hypertension is a rare disease, associated with a significant deterioration in quality of life, usually not curable and with an ominous prognosis. It is classified into five groups according to similar pathophysiological, clinical, haemodynamic, and treatment options in each of them.
Sustained VA is well tolerated in the LVAD patient but can result in implantable defibrillator (ICD) shocks, right ventricular failure, hospitalizations, and reduced quality of life. Several questions, however, remain regarding the efficacy of ICD and CRT following CF-LVAD. Moreover, optimal CIED programming after CF-LVAD implantation.
As the study demonstrates, a heart-healthy diet from a young age can lead to substantial long-term benefits, potentially reducing the burden of cardiovascular diseases and improving quality of life. Original article: Repo O et al. European Heart Journal.
Treatment with aficamten in patients with obstructive hypertrophic cardiomyopathy (oHCM) was associated with broad clinical efficacy across multiple outcome domains, including rapid and sustained decreases in outflow gradients, meaningful improvements in functional class and quality of life, enhanced exercise capacity, and significant reductions in (..)
Abstract Aims Patients with heart failure and reduced ejection fraction (HFrEF) exhibit skeletal muscle pathology, which contributes to symptoms and decreased quality of life. Additional experiments in mice treated with SGLT2 inhibitors confirmed positive effects of these drug agents on muscle health.
Final follow-up at six months included clinical and weight data and a quality-of-life questionnaire. Patients randomised to clinical follow-up received nurse-led telephone calls every two weeks, while those in the app arm received automated reminder messages every two weeks. Sixty-four patients underwent randomisation.
We plan to perform this systematic review and meta-analysis to compare the differences in functional capacity (FC) (measured in peak oxygen uptake (PVO 2 )) and health-related quality of life (hr-QoL) between telecardiac rehabilitation and both centre-based cardiac rehabilitation (CBCR) and usual care (UC) separately.
CSS, carotid sinus syndrome; CSM, carotid sinus massage; HR, heart rate; SF-36 QLQ, SF-36 quality-of-life questionnaire. Cardioneuroablation could be a reasonable alternative to pacemaker implantation in symptomatic carotid sinus syndrome. Results A total of 13 consecutive patients (84.6% male, mean age 63.812.3 years) were included.
This study aimed to assess quality-of-life (QOL) and healthcare utilization (HCU) benefits experienced by Q-FFICIENCY study participants. Participants underwent pulmonary vein isolation with very high-power short-duration (vHPSD) mode (90 W, ≤4 s) alone or combined with conventional-power temperature-controlled (CPTC) mode (25–50 W).
Secondary endpoints included changes in submaximal exercise capacity and quality of life. Conclusion In patients with advanced heart failure and LVAD, 12 weeks of exercise training did not improve peakVO 2 but demonstrated positive effects on submaximal exercise capacity and physical quality of life.
This 2023 Cochrane review of 60 randomized trials in 8728 heart failure patients, confirms the benefits of participation in exercise-based cardiac rehabilitation (ExCR), including reduced risk of hospitalization and a clinically meaningful improvement in health-related quality of life. Sixty trials (8728 participants) were included.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content